| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.04 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |